Class | Chemicals | Abbreviations | CAS No. | Venders | Major mode of genotoxicity |
---|---|---|---|---|---|
Non-genotoxins | Sodium dodecyl sulfate | SDS | 151-21-3 | Sigma-Aldrich, St. Louis, MO, USA | - |
Sodium chloride | NaCl | 7647-14-5 | Wako Pure Chemical Corporation, Osaka, Japan | - | |
D-Mannitol | D-Man | 69-65-8 | Sigma-Aldrich | - | |
Nalidixic acid | NA | 389-08-2 | Sigma-Aldrich | - | |
Clastogens | Methyl methanesulfonate | MMS | 66-27-3 | Sigma-Aldrich | Guanine N7 alkylation |
N-ethyl-N-nitrosourea | ENU | 759-73-9 | Sigma-Aldrich | Guanine O6 alkylation | |
Mitomycin C | MMC | 50-07-7 | Kyowa Hakko Kirin, Tokyo, Japan | Cross-linking | |
Cisplatin | CDDP | 15663-27-1 | Sigma-Aldrich | Cross-linking | |
Irinotecan | CPT | 100286-90-6 | Sawai Pharmaceutical, Osaka, Japan | Topo I inhibitor | |
Etoposide | ETP | 33419-42-0 | Sigma-Aldrich | Topo II inhibitor | |
Banzo[a]pyrene | BaP | 50-32-8 | Sigma-Aldrich | Guanine N2 alkylation by metabolic activation | |
Cyclophosphamide | CP | 6055-19-2 | Sigma-Aldrich | Guanine N7 alkylation by metabolic activation | |
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine hydrochloride | PhIP | 105650-23-5 | Wako Pure Chemical Corporation | Guanine C8 alkylation by metabolic activation | |
Aneugens | Colchicine | COL | 64-86-8 | Sigma-Aldrich | Microtubule-disruption |
Vinblastine sulfate salt | VBS | 143-67-9 | Sigma-Aldrich | Microtubule-disruption | |
Griseofulvin | GF | 126-07-8 | Sigma-Aldrich | Microtubule-disruption | |
Paclitaxel | PT | 33069-62-4 | Sigma-Aldrich | Microtubule-disruption |